Portfolio manager comments — Q3 2025
The fund declined by approximately 2.1% during the third quarter of 2025, while its benchmark, the Solactive ISS ESG Screened Europe Small Cap Index NTR, increased by around 0.2%. The market during the quarter was characterized by a consolidation phase, in which the earlier gains from the year weakened and the index as a whole traded largely sideways. Political uncertainty in France increased following the resignation of the Prime Minister after a vote of no confidence. President Emmanuel Macron has now appointed a new Prime Minister and budget negotiations have commenced, providing a measure of stability. Small‑cap equities have once again begun to outperform large‑caps during the year, strengthening as a group, which supports the fund’s investment focus.
The strongest positive contributors to the fund’s return during the quarter included Atalaya Mining, Erste Group Bank, Do & Co, Applied Nutrition, CTP, Innoscripta, Medcap, and Genmab. The largest detractors were Persimmon, CTS Eventim, Games Workshop, Vusion Group, and Amplifon. During the period, the fund initiated new positions in Salmar, Bechtle, Trigano, and Avanza. These investments were primarily financed through sales of holdings in Wallenstam, Peel Hunt, Pullup Entertainment, Liontrust Asset Management, and AB Dynamics.
We note that European small‑cap equities have begun to regain ground versus large‑caps after an unusually long period of relative underperformance. From a historical valuation perspective, European small‑caps continue to appear more attractive than their larger counterparts. The EU’s increased focus on reducing regulatory burdens and promoting growth and investment is, in our assessment, positive for the region. We also observe that smaller companies are better positioned to quickly implement AI solutions, potentially generating competitive advantages in the future.
The fund’s cautious view on the economic cycle is supported by the thematic growth drivers among our holdings, which contribute to a likely earnings expansion for the portfolio even in a continued weak macroeconomic environment.